Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CARDIOVASCULAR DISEASE

Immunotherapy for heart injury

Nature 573, 430–433 (2019)

T cells can be programmed to help damaged hearts. Normally, an injury to the heart, such as a heart attack, activates a subclass of cells known as cardiac fibroblasts, which deposit additional extracellular matrix proteins, resulting in fibrosis, which worsens heart function and signals to cardiomyocytes, negatively impacting their function.

Credit: Mutlu Kurtbas / E+ / Getty

A group of scientists in the United States and Germany engineered T cells that identify the pathological fibroblast using a protein unique to the latter cells. They show in mice that, following heart injury, the engineered T cells are able to eliminate the fibroblasts that have gone awry in the heart and improve cardiac function.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hannah Stower.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stower, H. Immunotherapy for heart injury. Nat Med 25, 1799 (2019). https://doi.org/10.1038/s41591-019-0688-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0688-8

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing